Promoter of Suven Pharma, Advent International, had said last year that it would merge the two businesses post the buyout of its significant stake in Suven Pharma. Under the merger, shareholders of Cohance will be issued 11 shares of Suven Pharma for every 295 shares held by the former. The new shares of Suven will be traded on the NSE and BSE.

Related Keywords

India , Mumbai , Maharashtra , Suven Pharma , Suven Pharmaceuticals Ltd , Cohance Lifesciences Ltd On , Advent International , Pharmaceuticals Ltd , Cohance Lifesciences Ltd , Suven Pharmaceuticals Shares , Cohance Lifesciences , Cohance Lifesciences Suven Pharma Merger , Cohance Lifesciences News , Suven Pharmaceuticals Share Price ,